US HB7269 | 2019-2020 | 116th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on June 18 2020 - 25% progression, died in committee
Action: 2020-06-18 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 18 2020 - 25% progression, died in committee
Action: 2020-06-18 - Referred to the House Committee on Energy and Commerce.
Pending: House Energy And Commerce Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To amend the Federal Food, Drug, and Cosmetic Act to establish a time-limited provisional approval pathway, subject to specific obligations, for certain drugs and biological products, and for other purposes.
Title
Promising Pathway Act
Sponsors
Rep. Mike Quigley [D-IL] | Rep. Mike Gallagher [R-WI] | Rep. Eric Swalwell [D-CA] | Rep. Bruce Westerman [R-AR] |
Rep. Jeff Van Drew [R-NJ] | Rep. Grace Napolitano [D-CA] | Rep. Don Bacon [R-NE] | Rep. Brian Fitzpatrick [R-PA] |
Rep. Angela Craig [D-MN] | Rep. Peter King [R-NY] | Rep. Joyce Beatty [D-OH] | Rep. Ted Yoho [R-FL] |
History
Date | Chamber | Action |
---|---|---|
2020-06-18 | House | Referred to the House Committee on Energy and Commerce. |
2020-06-18 | House | Introduced in House |
Same As/Similar To
SB3872 (Same As) 2020-06-03 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Subjects
Cardiovascular and respiratory health
Civil actions and liability
Congressional oversight
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Employee benefits and pensions
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health information and medical records
Immunology and vaccination
Infectious and parasitic diseases
Licensing and registrations
Manufacturing
Medical research
Medical tests and diagnostic methods
Prescription drugs
Scientific communication
Civil actions and liability
Congressional oversight
Drug safety, medical device, and laboratory regulation
Emergency medical services and trauma care
Employee benefits and pensions
Government information and archives
Government studies and investigations
Health
Health care costs and insurance
Health care coverage and access
Health information and medical records
Immunology and vaccination
Infectious and parasitic diseases
Licensing and registrations
Manufacturing
Medical research
Medical tests and diagnostic methods
Prescription drugs
Scientific communication
US Congress State Sources
Type | Source |
---|---|
Summary | https://www.congress.gov/bill/116th-congress/house-bill/7269/all-info |
Text | https://www.congress.gov/116/bills/hr7269/BILLS-116hr7269ih.pdf |